Pharmaceutical Prices in the 21st Century

✍ Scribed by Zaheer-Ud-Din Babar (eds.)

Publisher: ADIS
Year: 2015
Tongue: English
Leaves: 410
Edition: 1
Category: Library

No coin nor oath required. For personal study only.

✦ Synopsis

This book provides an overview of the global pharmaceutical pricing policies. Medicines use is increasing globally with the increase in resistant microbes, emergence of new treatments, and because of awareness among consumers. This has resulted in increased drug expenditures globally. As the pharmaceutical market is expanding, a variety of pharmaceutical pricing strategies and policies have been employed by drug companies, state organizations and pharmaceutical pricing authorities.

✦ Table of Contents

Front Matter....Pages i-x
Pharmaceutical Pricing Policies in Australia....Pages 1-23
Drug Pricing in Canada....Pages 25-41
Pharmaceutical Pricing Policies in China....Pages 43-58
Pharmaceutical Pricing in Egypt....Pages 59-78
Pharmaceutical Pricing in Ethiopia....Pages 79-91
Drug Prices in Finland....Pages 93-112
Pharmaceutical Prices in India....Pages 113-130
Pharmaceutical Pricing Policies in Italy....Pages 131-150
Pharmaceutical Pricing Policies in South Korea....Pages 151-169
Pharmaceutical Pricing in Malaysia....Pages 171-188
Pharmaceutical Pricing in New Zealand....Pages 189-207
Pharmaceutical Pricing Policies in Norway and Sweden....Pages 209-227
Pharmaceutical Pricing Policies in Qatar....Pages 229-249
Pharmaceutical Pricing in South Africa....Pages 251-265
Politics, Reforms, and Regulation of Pharma Prices and Expenditures in Turkey over the 2000s....Pages 267-295
Pharmaceutical Pricing Policies in the Gulf Countries’ Council (GCC) and the United Arab Emirates (UAE)....Pages 297-307
The Healthcare System and Pharmaceutical Prices in United States....Pages 309-319
Pharmaceutical Pricing Policies in Vietnam....Pages 321-342
Pharmaceutical Pricing in Europe....Pages 343-370
UK Health Technology Assessment and Value Based Pricing....Pages 371-388
Drug Prices and Incentives to Innovation by the Pharmaceutical Industry....Pages 389-401
The Pharmaceutical Policy Environment and Pharmaceutical Pricing Policies....Pages 403-411

✦ Subjects

Health Economics

📜 SIMILAR VOLUMES

Pharmaceutical Prices in the 21st Centur

📁 Pharmaceutical Prices in the 21st Century

✍ Babar, Zaheer-ud-din 📂 Library 📅 2015 🏛 Springer International Publishing, Cham 🌐 English

Pharmaceutical Marketing in the 21st Cen

📁 Pharmaceutical Marketing in the 21st Century

✍ Mickey Smith (Author) 📂 Library 📅 1997 🏛 CRC Press

<p>Pharmaceutical Marketing in the 21st Century helps professionals in the pharmaceutical field anticipate and prepare for market changes and advances, and it guides them in adjusting their marketing strategies to remain competitive in the coming era. Ideal for product managers, planners, and strate

The pharmaceutical industry : better med

📁 The pharmaceutical industry : better medicine for the 21st century

✍ Malinda Miller 📂 Library 📅 2011 🏛 Mason Crest Publishers 🌐 English

The Capital Asset Pricing Model in the 2

📁 The Capital Asset Pricing Model in the 21st Century: Analytical, Empirical, and Behavioral Perspectives

✍ Haim Levy 📂 Library 📅 2012 🏛 Cambridge University Press 🌐 English

The Capital Asset Pricing Model (CAPM) and the mean-variance (M-V) rule, which are based on classic expected utility theory, have been heavily criticized theoretically and empirically. The advent of behavioral economics, prospect theory and other psychology-minded approaches in finance challenges th

The Capital Asset Pricing Model in the 2

📁 The Capital Asset Pricing Model in the 21st Century: Analytical, Empirical, and Behavioral Perspectives

✍ Professor Haim Levy 📂 Library 📅 2011 🏛 Cambridge University Press 🌐 English

EPR in the 21st Century

📁 EPR in the 21st Century

✍ Asako Kawamori, Jun Yamauchi, Hitoshi Ohta 📂 Library 📅 2002 🏛 Elsevier Science 🌐 English

The Proceedings in this volume are a refereed selection of presentations from The Third Asia-Pacific EPR/ESR Symposium (APES'01), held in Kobe, Japan from October 29 to November 1, 2001. Participants from 20 countries from Asia, Australia, Europe, North and South America presented 210 papers, of whi